Detalhe da pesquisa
1.
Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation.
Annu Rev Immunol
; 38: 511-539, 2020 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32340578
2.
Immune Response to Dengue and Zika.
Annu Rev Immunol
; 36: 279-308, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29345964
3.
Multimodal integration of carbon dioxide and other sensory cues drives mosquito attraction to humans.
Cell
; 156(5): 1060-71, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24581501
4.
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Nat Immunol
; 17(9): 1102-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339099
5.
The Perfect Appetizer: A Pharmacological Strategy for a Non-biting Mosquito.
Cell
; 176(4): 679-681, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735629
6.
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Cell
; 139(7): 1243-54, 2009 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064371
7.
Small-Molecule Agonists of Ae. aegypti Neuropeptide Y Receptor Block Mosquito Biting.
Cell
; 176(4): 687-701.e5, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735632
8.
Travel Surveillance and Genomics Uncover a Hidden Zika Outbreak during the Waning Epidemic.
Cell
; 178(5): 1057-1071.e11, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442400
9.
Immune response to dengue virus and prospects for a vaccine.
Annu Rev Immunol
; 29: 587-619, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21219187
10.
Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis.
Cell
; 175(7): 1931-1945.e18, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550790
11.
Author Correction: Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.
Nat Immunol
; 21(3): 354, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001822
12.
What Came First-the Virus or the Egg?
Cell
; 168(5): 755-757, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28235193
13.
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.
Cell
; 169(4): 597-609.e11, 2017 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475892
14.
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.
Cell
; 170(2): 273-283.e12, 2017 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28708997
15.
Modified mRNA Vaccines Protect against Zika Virus Infection.
Cell
; 168(6): 1114-1125.e10, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222903
16.
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
Nat Immunol
; 20(10): 1291-1298, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477918
18.
Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components.
Cell
; 165(5): 1255-1266, 2016 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160350
19.
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.
Nature
; 523(7562): 612-6, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26123020
20.
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.
Nat Immunol
; 19(11): 1248-1256, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323338